SelenBio

SelenBio

Closed: Apr. 2020

About this raise

SelenBio, a biotechnology company with a post-money valuation of $20.7 million, is raising funds on NetCapital. The company develops an antibacterial technology that prevents the formation of biofilm in dental, medical, industrial, and consumer applications. SelenBio uses a unique selenium-based compound, SELDOX, to keep the applications infection-free. The company was founded by Kenny Gallagher and Karl Doenges. The proceeds of the current crowdfunding round, with a minimum target of $10,000 and a maximum target of $1,070,000, will be used for research & development, operations, completion of current projects, sales & marketing, and compensation for managers. SelenBio is working on multiple projects with excellent traction and has already received the FDA approval for SELDOX.

Expand

Investment Overview

Invested this round: $147,972

Deal Terms

Total Commitments

Platform
Netcapital
Start Date
10/03/2019
Close Date
04/28/2020
Min. Goal
$10,000
Max Goal
$1,070,000
Min. Investment

$4

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$4.00

Pre-Money Valuation

$19,621,196

Company & Team

Company

Year Founded
2017
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
High
Capital Intensity
High
Location
Austin, California
Business Type
High Growth
Company Website
Visit Website

Team

Employees
3
Founder Name
Kenny Gallagher
Title
CEO
Founder Name
Karl Doenges
Title
Co-Founder and Board Member

Financials

 Revenue
$12,142
 Monthly Burn
$37,828
 Runway
14.6 months
Gross Margin
3%

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$12,142

$1,039

COGS

$11,785

$871

Tax

$0

$0

 

 

Net Income

$-453,939

$-134,867

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$550,794

$104,479

Accounts Receivable

$153

$213

Total Assets

$1,044,713

$475,538

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/28/2020 Netcapital $19,621,196 $147,972 Equity - Common Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
SelenBio on Netcapital
Platform: Netcapital
Security Type: Equity - Common
Valuation: $19,621,196
Price per Share: $4.00

Follow company

Follow SelenBio on Netcapital

Buy SelenBio's Deal Report

Warning: according to the close date for this deal, SelenBio may no longer be accepting investments.

SelenBio Deal Report

Get Kingscrowd's comprehensive report on SelenBio including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether SelenBio is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the SelenBio deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge